In conclusion, we demonstrate that CD147-CAR can effectively redirect human immune cells (primary T, primary NK, and NK-92MI cells) to target malignant HCC cells with limited fratricide in vitro and in vivo. Here, BSG is linked to hepatocellular carcinoma.